CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as administrative agent and joint lead arranger on the funding of a senior credit facility to support the acquisition of Medusind by private equity sponsor Alpine Investors. Founded in 2002 and based in Miami, Florida, Medusind is a leading provider of technology solutions and revenue cycle management services … [Read more…]

Presentations demonstrate therapeutic potential of Turnstone’s selected tumor-infiltrating lymphocyte therapy in a broad range of solid tumors and support ongoing clinical efforts for its lead program, TIDAL-01 SAN DIEGO–(BUSINESS WIRE)–#AACR2023–Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat solid tumors, today announced that two abstracts have been accepted for poster presentations at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bird Flu Treatment Market Research Report by Type (Antivirals, Combination Treatment, Prophylactic Antibiotics), End-User (Clinics, Hospital, Institutional Health Centers) – Global Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The Global Bird Flu Treatment Market size was estimated at USD 20.42 billion in 2022, USD 22.06 billion in 2023, and is projected … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Medical Device Partnering Terms and Agreements 2016-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Medical Device Partnering Terms and Agreements 2016-2023 report provides comprehensive access to available deals and contract documents for over 1,700 medical device deals. This report provides details of the latest medical device agreements announced in the … [Read more…]

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–Lysando AG – market leader in the field of antimicrobial proteins – is pleased to announce that Dr. Yong Chul Shin has joined the team as CSO in April. Dr. Shin will be responsible for leading the company’s scientific strategy and represents Lysando in science-related communication – particularly to the Korean market. Dr. … [Read more…]

Proceeds will fund: – Clinical programs ALE.F02 and ALE.C04 – two first-in-class anti-Claudin-1 (CLDN1) antibodies for organ fibrosis and CLDN1 positive tumors – The platform to engineer CLDN1 antibody drug conjugates (ADC) and bi-specific antibodies BASEL, Switzerland–(BUSINESS WIRE)–Alentis Therapeutics (“Alentis”), the Claudin-1 (CLDN1) company, is a clinical-stage biotech developing breakthrough treatments for organ fibrosis and … [Read more…]

‒ Vabysmo data suggest rapid and robust drying of retinal fluid in patients with wet age-related macular degeneration and diabetic macular edema – ‒ Real-world studies of Vabysmo demonstrate ability to extend treatment intervals in the first four months while maintaining visual acuity – ‒ Clinical data on an investigational anti-interleukin-6 treatment in uveitic macular … [Read more…]

FOSTER CITY, Calif.–(BUSINESS WIRE)–#alagillesyndrome–Mirum Pharmaceuticals, Inc. (“Mirum”) (Nasdaq: MIRM) today announced the pricing of its offering of $275.0 million aggregate principal amount of 4.00% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#HIV–UNAIDS released a report today, reiterating the many public health, economic, and social benefits of fully funding the global HIV/AIDS response while acknowledging the difficulty of fundraising. AHF supports the authors’ argument that, in addition to mobilizing new resources, there is a need to achieve higher efficiencies in how treatment, retention in care, … [Read more…]

GARDENA, Calif.–(BUSINESS WIRE)–#alternativemedicine–Daiwa Health Development, a leading provider of natural health and wellness products, announces the launch of its new product, Daiwa GastroImmune™. Powered by ImmunoLin®, this dietary supplement helps support digestive function and a healthy mucosal immune system. ImmunoLin® is an agglomerated powder purified from edible bovine plasma that contains more than 50% immunoglobulins, … [Read more…]